On Monday at 2:35 PM (Bangkok time), the share price of Com7 Public Company Limited (SET: COM7) dropped by 3.70% or THB 1.00 to THB 26.00, with a trading value of THB 241.65 million.
KGI Securities (Thailand) noted in its report, recommending a ‘Hold’ rating for COM7 and set a target price by the end of 2025 at THB 31 per share. The analyst expressed apprehensions regarding intensified competition expected in 2025, prompting the company to initiate marketing initiatives.
This competitive environment may potentially impact margins, even as COM7 expands its business segments with entities like DR.Pharma, PetPaw, and Gold Integrate. However, these additional ventures may not yet be as robust as desired by the company. KGI projected that COM7 would need to allocate higher expenses towards enhancing its business operations.
